Alkymos

Lexington, United States Founded: 2006 • Age: 20 yrs
Specializes in chelators and chelator-based filtration devices.

About Alkymos

Alkymos was a Chemicals & Materials company based in Lexington (United States) founded in 2006 by Robert Yokel. It specializes in chelators and chelator-based filtration devices. It operates on a B2B model. Alkymos has raised $643.5 thousand across 8 funding rounds from investors including HHS, SBIR and Enterprise Angels Community Fund I. Its website alkymos.com draws about 681 thousand monthly visits. The company is recorded as dissolved. Its focus areas include Manufacturing, Chemical Products, Filtration Devices and Chelator-Based. Its competitors include Cytosorbents, TeraPore and Vanguard Scientific Systems; 3 of its 3 listed competitors have raised funding.

Company details

Alkymos, established in 2006, excels in producing manufactured goods, chemical products, filtration devices, and chelator-based. Specializes in chelators and chelator-based filtration devices. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Lexington, United States
  • Founders Robert Yokel
  • Sectors
    Chemicals & Materials
  • Website alkymos.com
Key Metrics
  • Total Equity Funding
    $643.5K (USD)

    in 8 rounds

  • Latest Funding Round
    $425K (USD), Seed

    Mar 2015

  • Investors
    HHS

    & 2 more

Funding Insights of Alkymos

Alkymos has successfully raised a total of $643.5K across 8 strategic funding rounds. The most recent funding activity was a Seed round of $425 thousand completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $643,500
  • Total Rounds 8
  • Last Round Seed β€” $425,000
  • First Round $760,562

    (Dec 2006)

  • Investors Count 3

All 8 funding rounds of Alkymos with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2015$425,000Seed––
–
Dec 2014Seed–Enterprise Angels Community Fund I
–
Nov 2013$218,500Seed––
–
Mar 2011$500,000Grant––
May 2010$760,562Grant––
Mar 2008$99,646Grant––
Feb 2008$99,646Grant––
Dec 2006$760,562Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Alkymos

Alkymos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, SBIR and Enterprise Angels Community Fund I.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
enterpriseangelsfund.com
Federal innovation and scientific achievement services are provided.
1982sbir.govLithia Springs, United States
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Alkymos

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Alkymos

1 people are tracked at Alkymos (1 in leadership).

NameRoleGroup
Robert Yokel
Founder, PresidentLeadership
Premium access

Complete people profiles for Alkymos

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Alkymos

3 dated milestones of Alkymos across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Alkymos is founded.
  2. Funding First funding round of $761K.
  3. Funding Latest funding round, Seed, of $425K.

Competitors of Alkymos

Alkymos has 3 listed competitors in our database, 3 of them funded. They include Cytosorbents, TeraPore and Vanguard Scientific Systems.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cytosorbents.com1997Monmouth Junction, United States$22.04M198
Hemoperfusion technology is developed to remove toxins from blood.
terapore.com2013San Francisco, United States$19.53M16
Developer of bioseparation solutions for therapeutics and novel biologics
vanguardscientific.com2015Oregon, United States$2.65M
Creates innovative equipment for botanical extraction industries.
Premium access

Detailed competitors of Alkymos

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Alkymos

The website of Alkymos (alkymos.com) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with Alkymos. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Alkymos

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Water & Environmental Treatment Chemicals

2 companies that operate in the same segment as Alkymos (Water & Environmental Treatment Chemicals) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of water treatment chemicals
1999San Marcos, Texas, United States
Coatings, pharmaceutical intermediates, nutrition, and water treatment products are manufactured.
2018Bound Brook, New Jersey, United States31
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Alkymos

Alkymos was founded in 2006.

Alkymos is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.

Alkymos is a funded company, having raised a total of $643.5K across 8 funding rounds to date. The company's 1st funding round was a Grant of $760.56K, raised on Dec 2006.

Alkymos, established in 2006, excels in producing manufactured goods, chemical products, filtration devices, and chelator-based. Specializes in chelators and chelator-based filtration devices. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

Alkymos's top competitors include Cytosorbents, TeraPore and Vanguard Scientific Systems.

Alkymos has 3 investors. Key investors include HHS, SBIR, and Enterprise Angels Community Fund I.

The website of Alkymos receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available